|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400083951 |
|
最近更新日期: Date of Last Refreshed on: |
2024-05-08 10:30:41 |
|
注册时间: Date of Registration: |
2024-05-08 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
巨刺联合重复经颅磁刺激对脑卒中患者恢复期运动功能的疗效研究 |
|
Public title: |
The therapeutic effect of contralateral acupuncture combined with repeated transcranial magnetic stimulation on motor function in stroke patients during the recovery period |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
巨刺联合重复经颅磁刺激对脑卒中患者恢复期运动功能的疗效研究 |
|
Scientific title: |
The therapeutic effect of contralateral acupuncture combined with repeated transcranial magnetic stimulation on motor function in stroke patients during the recovery period |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
宋振旺 |
研究负责人: |
王杰宁 |
|
Applicant: |
Song Zhenwang |
Study leader: |
Wang Jiening |
|
申请注册联系人电话: Applicant telephone: |
+86 178 3997 4348 |
研究负责人电话: Study leader's telephone: |
+86 139 0163 4270 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
shxzhysong321@163.com |
研究负责人电子邮件: Study leader's E-mail: |
drwjn0606@sina.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
中国上海市浦东新区高桥镇高荷路380号8601 |
研究负责人通讯地址: |
中国上海市浦东新区高桥镇大同路358号 |
|
Applicant address: |
8601, No. 380 Gaohe Road, Gaoqiao Town, Pudong New Area, Shanghai, China |
Study leader's address: |
358 Datong Road, Gaoqiao Town, Pudong New Area, Shanghai, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
上海中医药大学 |
||
|
Applicant's institution: |
Shanghai University of Traditional Chinese Medicine |
||
|
研究负责人所在单位: |
上海中医药大学附属第七人民医院 |
||
|
Affiliation of the Leader: |
Shanghai University of Traditional Chinese Medicine Affiliated Seventh People's Hospital |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2024-7th-HIRB-025 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
上海市第七人民医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Shanghai Seventh People's Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-04-23 00:00:00 |
||
|
伦理委员会联系人: |
张春燕 |
||
|
Contact Name of the ethic committee: |
Zhang Chunyan |
||
|
伦理委员会联系地址: |
上海市浦东新区高桥镇大同路358号1号楼辅楼203室 |
||
|
Contact Address of the ethic committee: |
Room 203, Auxiliary Building, Building 1, No. 358 Datong Road, Gaoqiao Town, Pudong New Area, Shanghai |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 21 5867 0561 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
上海市第七人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Shanghai Seventh People's Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
上海市浦东新区高桥镇大同路358号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 358 Datong Road, Gaoqiao Town, Pudong New Area, Shanghai |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
raise independently |
||||||||||||||||||||||
|
Target disease: |
cerebral apoplexy |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
I期临床试验 | ||||||||||||||||||||||
|
Study phase: |
1 |
||||||||||||||||||||||
|
研究设计: |
横断面 |
||||||||||||||||||||||
|
Study design: |
Cross-sectional |
||||||||||||||||||||||
|
研究目的: |
本研究采用随机对照试验1:1优效性实验设计,对照组常规患侧针刺基础上联合rTMS,试验组将在对照组基础上加健侧针刺。根据随机对照原则,在对照组健侧采用非侵入式假针刺。评估巨刺联合rTMS对脑卒中偏瘫肢体功能障碍的疗效,观察患者肢体功能、日常生活能力等方面的改善情况。探讨巨刺联合rTMS的作用机制,研究其对脑卒中偏瘫患者神经功能的影响,从神经传导、精准神经环路调控等方面的变化探究针刺和重复经颅磁刺激各自发挥作用的机制以及联合治疗疗效的机理。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study adopted a randomized controlled trial with a 1:1 superiority experimental design. The control group received conventional acupuncture on the affected side in combination with rTMS, while the experimental group received acupuncture on the healthy side in addition to the control group. Evaluate the therapeutic effect of the combination of giant needling and rTMS on stroke hemiplegic limb dysfunction, and observe the improvement of limb function, daily living ability, and other aspects in patients. Explore the mechanism of action of the combination of giant needling and rTMS, investigate its impact on the neurological function of stroke hemiplegic patients, and explore the mechanisms of acupuncture and repetitive transcranial magnetic stimulation in terms of changes in nerve conduction, precise neural circuit regulation, and the therapeutic effect of the combination therapy. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
(1)脑卒中发病后2周~6个月; (2)首次发病,单侧病灶,病变部位为单侧皮质下脑卒中(基底核、丘脑、内囊、放射冠)者,出现上肢肢体一侧运动功能障碍; (3)自愿参加本临床试验,本人或家属签署知情同意书; |
||||||||||||||||||||||
|
Inclusion criteria |
(1) 2 weeks to 6 months after the onset of stroke; (2) First onset, unilateral lesion, located in a unilateral subcortical stroke (basal nucleus, thalamus, internal capsule, corona radiata), with motor dysfunction on one side of the upper limb; (3) Voluntarily participate in this clinical trial, and either the individual or their family member signs an informed consent form; |
||||||||||||||||||||||
|
排除标准: |
(1)脑外伤、脑肿瘤及颅脑术后等非脑血管病变原因所致的偏瘫者; (2)有严重的心、肺、肝、肾等器官功能衰竭者; (3)既往有过脑卒中发作史和/或遗留有肢体功能障碍者; (4)依从性差,不按医嘱进行治疗者; (5)存在偏侧忽略或偏盲者; (6)针刺不耐受的患者;排除孕妇; (7)存在出血倾向者;伴有脑肿瘤、动脉畸形、静脉畸形者;患有严重心脏瓣膜病、心源性栓塞者等; (8)体内含有心脏起搏器、支架、人工耳蜗等金属器件等不适宜进行经颅磁刺激的患者; (9)存在与放电线圈紧密接触的金属硬件(如耳蜗植入物、内部脉冲发生器或药物泵)。 (10)头颅内有由银和金制成的电极,金属脑植入物。 (11)体内的电子元件(如位于颈部或躯干的IPG)与TMS线圈的距离小于10cm的患者(如:心脏起搏器、迷走神经刺激系统和脊髓刺激器)禁用。 (12)深部脑刺激植入脉冲发生器与经颅磁刺激线圈距离小于10cm的患者禁用; (13)有癫痫发作史、频繁的头疼耳鸣及药物滥用,近两周使用麻醉学镇痛药物。 |
||||||||||||||||||||||
|
Exclusion criteria: |
(1) Hemiplegia caused by non cerebrovascular diseases such as traumatic brain injury, brain tumor, and postoperative brain surgery; (2) Individuals with severe organ failure such as heart, lung, liver, and kidney; (3) Individuals with a history of stroke and/or residual limb dysfunction; (4) Poor compliance and failure to follow medical advice for treatment; (5) Individuals with unilateral neglect or blindness; (6) Patients with acupuncture intolerance; Excluding pregnant women; (7) Individuals with a tendency towards bleeding; Patients with brain tumors, arterial malformations, and venous malformations; Individuals with severe heart valve disease, cardioembolic conditions, etc; (8) Patients whose bodies contain metal devices such as pacemakers, stents, and cochlear implants that are not suitable for transcranial magnetic stimulation; (9) There are metal hardware in close contact with the discharge coil, such as cochlear implants, internal pulse generators, or drug pumps. (10) There are electrodes made of silver and gold in the skull, as well as metal brain implants. (11) Patients with electronic components (such as IPG located in the neck or torso) within a distance of less than 10cm from the TMS coil (such as pacemakers, vagus nerve stimulation systems, and spinal cord stimulators) are prohibited from using electronic components within the body. (12) Patients with a distance of less than 10cm between the implanted pulse generator for deep brain stimulation and the transcranial magnetic stimulation coil are prohibited; (13) Having a history of epileptic seizures, frequent headaches, tinnitus, and drug abuse, using anesthetic analgesics in the past two weeks. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-05-01 00:00:00至 To 2025-05-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2024-05-13 00:00:00 至 To 2025-05-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
简单随机数字序列法,由研究负责人使用SPSS27.0随机数字生成法产生随机序列,种子号20240403。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Simple random number sequence method, generated by the research leader using SPSS 27.0 random number generation method, seed number 20240403. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
单盲,医师或治疗师在评估患者运动功能时不知道患者的具体分组 |
|
Blinding: |
Single blind, physicians or therapists do not know the specific grouping of patients when evaluating their motor function |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
中国临床试验注册中心临床试验公共管理平台 ResMan |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
ResMan |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form, CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
无/No |